I definetly see value in the risk reward here. There's not much...

I definetly see value in the risk reward here. There's not much volume, things are quite and there's some resilience under the 0.20 mark.

Based on current exploration, confirmed and inferred results, we know this project has potential and a set to see a lot of announcements throughout the next year realising what current holders know will be more strong assays. That should be enough alone to bring attention to this sleeper.

Moreover the collie processing facility construction is underway and will bring cashflow to the company in the long term.

yes cash is short, but no more then what we see in other microcap specs. Government support will be enough to fund our exploration and R&D at collie.
I don't see us going broke, and I don't see a cap raise for atleast 6months when finalising collie and talks about the project beginning commence.

I see the board structure as one of the best of seen in specs and performance rights will only push these higher performing individuals to nurture their baby